The deorphanization of TRPV1 and the emergence of octadecadienoids as a new class of lipid transmitters.
Johnson & Johnson Pharmaceutical Research & Development, LLC, Titusville, NJ 08560, USA. cflores2@its.jnj.com
Christopher M
CM
Flores
Michael R
MR
Vasko
D008041:Linoleic Acids / Q000494:pharmacology*; D018377:Neurotransmitter Agents / Q000494:pharmacology*; D010146:Pain / Q000503:physiopathology*; D050916:TRPV Cation Channels / Q000819:agonists*
D008041:Linoleic Acids; D018377:Neurotransmitter Agents; D050916:TRPV Cation Channels; C494482:TRPV1 protein, human